AHA 2020 | Rise in Early Discharge After TAVR Has the Expected Cost

As hospitalization time after a transcatheter aortic valve replacement (TAVR) is reduced, we are observing a concomitant increase in re-hospitalizations due to conduction disorders. Early discharge is a great step, but it should be noted that conduction disorders can happen beyond 48 hours.

A few years ago, pacemaker implantation rates after discharge were about 7%; nowadays, that figure has almost been doubled.

Conduction system injury and its subsequent complete atrioventricular block is a well-known TAVR complication, whose prevalence rate varies according to prosthesis type, implantation technique, operator and center experience, etc. The worldwide trend to speed up patient discharge after TAVR has led to more indications for permanent pacemakers after the index hospitalization.

This paper, presented at the American Heart Association (AHA) 2020 Scientific Sessions and simultaneously published in JACC: Cardiovascular Interventions, describes this new reality.


Read also: AHA 2020 | POLYPILL: One Pill Plus Aspirin to Treat Everything.


The analysis included 62,083 patients registered in the United States database who underwent TAVR between 2012 and 2017. Out of all patients, 11% needed a permanent pacemaker after the procedure (most during the index hospitalization). During the study period, implantation rates were stable (p = 0.632 for trend).

Hospitalization time was significantly shortened from a mean 6 days in 2012 to just 2 days in 2017 (p < 0.0001).


Read also: The Most Read Scientific Articles in Interventional Cardiology.


The combination of shorter hospital stays and stable pacemaker rates means many patients underwent implantation in subsequent post-discharge visits.

Patients who present a high risk of atrioventricular block after discharge, those with right-sided bundle branch block, transient blockages after the procedure, a deep implant, or an oversized valve compared with annular dimensions should be considered for remote and continuous ambulatory monitoring.

mcp-y-tavi

Original title: Shifting trends in timing of pacemaker implantation after transcatheter aortic valve replacement.

Reference: Mazzella AJ et al. Presentado en el congreso AHA 2020 y publicado simultáneamente en J Am Coll Cardiol Intv. 2020.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...